Browsing by Author "Likic, I. (23497909500)"
Now showing 1 - 5 of 5
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Conservative management of massive hematoperitoneum caused by ovulation in a patient with severe form of von Willebrand disease - A case report(2012) ;Terzic, M. (55519713300) ;Likic, I. (23497909500) ;Pilic, I. (13612571200) ;Bila, J. (57208312057)Knezevic, N. (35302673900)Von Willebrand disease (VWD) is the most common inherited bleeding condition that involves extended or excessive bleeding, caused by the deficiency or defect of von Willebrand factor (VWF). Hematoperitoneum as a complication of gynecologic diseases represents acute condition which is usually caused by the hemorrhagic corpus luteum or a rupture of either ectopic pregnancy or a hemorrhagic ovarian cyst. The authors present a unique case of conservatively managed massive hematoperitoneum caused by ovulation in a patient with severe form of von Willebrand disease who had right adnexectomy due to hemorrhagic corpus luteum four months prior. This conservative management by blood product and factor concentrate support could be a method of choice in selected hemodynamically stable patients. Furthermore, recurrent bleeding episodes following ovulation could be prevented by suppression of ovulation using oral contraceptive pills. - Some of the metrics are blocked by yourconsent settings
Publication New approach of the treatment of von Willebrand's disease during pregnancy.(2005) ;Gojnic, Miroslava (9434266300) ;Fazlagic, A. (23496293200) ;Likic, I. (23497909500) ;Stefanovic, A. (8613866900) ;Vidakovic, S. (9434348100) ;Pervulov, M. (6602872337) ;Petkovic, S. (7005164142) ;Mostic, T. (6506343126) ;Miljic, P. (6604038486)Bogdanovic, A. (6603686934)AIM: The aim of the study was to analyze the effectiveness of the application of DDAVP (desmopressin) and Hemate P with cryoprecipitate pre- and postpartum in patients with von Willebrand disease. METHODS: We monitored 32 patients with von Willebrand disease during the study period 1993-2003. DDAVP was applied in the 36th/37th week of gestation and cryoprecipitate and fresh frozen plasma were applied 1 day before and 3 days after delivery. DDAVP treatment continued for 4 weeks. Factor VIII (Hemate P) at the day of delivery RESULTS: No complications occurred in the studied population. CONCLUSION: Precipitation of DDAVP, Hemate P, and cryoprecipitate may help in the treatment of pregnant women with von Willebrand disease. - Some of the metrics are blocked by yourconsent settings
Publication Ovarian carcinoma diagnostic challenge: Large ovarian carcinoma giving umbilical subcutaneous metastases without infiltrating intestines(2018) ;Pantovic, S. (55340482900) ;Stefanovic, A. (8613866900) ;Dotlic, J. (6504769174) ;Kadija, S. (21739901200) ;Jeremic, K. (6701486495) ;Likic, I. (23497909500) ;Repac, S. (57203869589) ;Stojnic, J. (13613250800) ;Vilendecic, Z. (23996155800)Pilic, I. (13612571200)Introduction: The authors present an interesting case of large ovarian carcinoma challenging for diagnosis (with lymphonodal and umbilical subcutaneous metastases, but without infiltrating intestines and therefore causing few symptoms). Case Report: A 63-year-old patient, almost completely asymptomatic, presented with large bilateral adnexal masses. ROMA index was elevated. Abdominal and pelvic MRI scan showed presence of 20-cm mixed-consistency tumors of both ovaries and lymphedema in periumbilical subcutis. Only two parailiacal lymph nodes were enlarged. Patient had total hysterectomy with bilateral adnexectomy, selective lymphadenectomy, and excision of subcutaneous tumor. The right tumor formed the incarceration of the intestines, without infiltrating the intestinal wall. Histopathological analysis diagnosed ovarian serous papillary adenocarcinoma with metastases in lymph nodes and umbilical region subcutis. Conclusion: This report highlights that, although very rare, one of the first ovarian carcinoma manifestations can be its subcutaneous/cutaneous metastases. Additionally, lack of clear symptoms can exist in even at the advanced stage. © 2018 S.O.G. CANADA Inc. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Predictive factors of malignancy in patients with adnexal masses(2013) ;Terzic, M. (55519713300) ;Dotlic, J. (6504769174) ;Likic, I. (23497909500) ;Ladjevic, N. (16233432900) ;Brndusic, N. (55624352300) ;Mihailovic, T. (36098086700) ;Andrijasevic, S. (55624306100) ;Pilic, I. (13612571200)Bila, J. (57208312057)Introduction: Good preoperative tumor triage is essential for choosing the appropriate approach. Objective: The study aim was to identify factors from standard preoperatively collected data, which could predict the nature of adnexal masses prior surgery. Material and Methods: The study involved all women treated in the Clinic for Gynecology and Obstetrics Clinical Center of Serbia for adnexal tumors throughout a period of 18 months. On admission, detailed anamnestical and laboratory data were obtained and ultrasound scans were performed. Obtained data were compared with hystopathological findings of tumors. Methods of correlation and logistic regression were applied to create association models. Results: Three new models for predicting tumor nature were achieved from anamnestical data, characteristics of women and tumors, and laboratory analyses. Two statistically significant (p = 0.000) equations were obtained for anamnestical data and characteristics of women and tumors, while three were made for laboratory analyses. Sensitivity of anamnestical malignancy index (AMI) was 73.33%, specificity 72.87%, positive predictive value (PPV) 39.49% and negative predictive value (NPV) 91.88%. Sensitivity of characteristic malignancy index (CMI) was 92.38%, specificity 67.36%, PPV 40.59% and NPV 97.34%. Sensitivity of laboratory malignancy index (LMI) was 56.45%, specificity 90.24%, PPV 68.63%, and NPV 84.57%. Conclusions: The best predictors of malignancy are menopausal status, body mass index (BMI), age, metastases, ascites, tumor marker CEA level, and erythrocyte sedimentation rate (ESR). Along with the risk of malignancy index (RMI), for more reliable triage and preoperative tumor evaluation the authors propose introduction of another three indexes (AMI, CMI, LMI) in clinical practice. - Some of the metrics are blocked by yourconsent settings
Publication The significance of Doppler flow in early detection of uterine sarcoma in older primigravida pregnancies(2005) ;Gojnic, M. (9434266300) ;Likic, I. (23497909500) ;Pervulov, M. (6602872337) ;Petkovic, S. (7005164142) ;Fazlagic, A. (23496293200)Vasiljevic, B. (25121541800)During a four-year period we analyzed the significance, sensitivity and sensibility of myoma Doppler flow during pregnancy in relation to the course and outcome of the pregnancy and to later histopathological findings. By following 36 older primigravidas with determined myomas, we observed the course of the pregnancies in all trimesters and analyzed myoma Doppler flow. In conditions where the resistance index showed the possibility of uterine sarcoma, the pregnancy was ended by surgery; not only was myomectomy performed but also complete uterine hysterectomy with the previous consent of the patient. Doppler flow was accepted as the authoritative parameter for non-invasive detection of a malignant process. Considering the obstetrical findings, other patients were delivered vaginally or operatively, but after puerperium they were subjected to control examinations and myomectomy because Doppler flow findings did not show any indications of sarcoma. By histopathological analysis, we received benign results in 31 cases, while in four cases where we decided on hysterectomy and surgical delivery, we received malignant results, i.e. leiomyosarcoma. In four cases of performed hysterectomy immediately after cesarean section, the resistance index (RI) of revascularization within the myoma was in the range between RI 0.30 ± 0.02. Flows within the uterine artery were 0.54 ± 0.03.
